Tyson Foods Cuts Profit Outlook, Asks “Where’s the Beef?”

3 weeks ago 15

Thornton McEnery

Mon, August 3, 2026 astatine 8:44 AM CDT 2 min read

Tyson Foods Cuts Profit Outlook, Asks "Where's the Beef?"

Tyson Foods Cuts Profit Outlook, Asks "Where's the Beef?" - Moby

BREAKING NEWS

Our analysts conscionable identified a banal with the imaginable to beryllium the adjacent Nvidia. Tell america however you put and we'll amusement you wherefore it's our #1 pick. Tap here.

There's a peculiar spirit of firm symptom reserved for companies whose earthy worldly besides moos.

Tyson Foods conscionable chopped its yearly nett forecast chiefly due to the fact that cattle present outgo much to bargain than steaks and burgers tin merchantability for. Shares dropped astir 3% premarket arsenic investors digested that these caller numbers aren't pretty. Fiscal 2026 adjusted operating income is present guided to $2.1 cardinal to $2.3 billion, trimmed from $2.2 cardinal to $2.4 billion. The beef conception unsocial is expected to suffer $500 cardinal to $650 million, a meaningfully uglier spread than the $350 cardinal to $500 cardinal Tyson was bracing for past quarter. Beef volumes fell 15.9% adjacent arsenic prices jumped 12.1%, the benignant of mathematics wherever selling little astatine a higher terms inactive someway adds up to worse.

Blame the cows, oregon really, the shortage of them. America's cattle herd has shrunk to its smallest size successful 75 years, a drought-driven casualty of scorched pastures and pricier feed. Washington's prohibition connected Mexican cattle imports, aimed astatine a flesh-eating pest with a sanction consecutive retired of a fearfulness movie, hasn't helped, though alleviation is supposedly coming this month.

One stock. Nvidia-level potential. 30M+ investors spot Moby to find it first. Get the pick. Tap here.

But chickenhearted is redeeming the day. As beef prices spook shoppers, they're trading down to poultry, and Tyson's chickenhearted concern grew margins 11.2% portion volumes ticked up 1%, softly propping up a institution whose flagship macromolecule has turned into a liability.

Total gross landed astatine $13.87 billion, missing the $14.12 cardinal Wall Street wanted, with full-year maturation present guided to 2.5% to 3.5% alternatively of the 4.3% analysts expected. Board subordinate Jeff Schomburger takes implicit arsenic CEO successful October, inheriting a institution wherever the chickenhearted helping is doing the dense lifting the steak was expected to handle.

Read Entire Article